Organization: National Research Council Canada
Year: 2024
Month: September
Request Number: A-2024-22
Request Summary: a. Requests for grants, investment, partnership or financial support by Medicago and responses given for: i. The development of vaccines against Covid-19, for the period of March 2020 and February 2023; ii. Clinical trials related to the Covid-19 vaccine, for the period of March 2020 and February 2023; iii. The construction of a vaccine manufacturing plant in Quebec, for the period of March 2020 and February 2023. b. Any document, including but not limited to emails, letters, forms, agreements, summaries, reports and tables, establishing: i. The amount of the grant(s) awarded to Medicago for - the development of vaccines against Covid-19 - clinical trials linked to the vaccine against Covid-19 - the construction of a vaccine manufacturing plant in Quebec, for the period from March 2020 and February 2023. ii. The conditions, terms and dates of payment of the amounts of the grant(s) awarded to Medicago for - the development of vaccines against Covid-19 - clinical trials linked to the vaccine against Covid-19 - the construction of a manufacturing plant of vaccines in Quebec, for the period from March 2020 to February 2023. iii. The conditions and terms of termination or withdrawal linked to the grant(s) awarded to Medicago for - the development of vaccines against Covid-19 - clinical trials linked to the vaccine against Covid-19 - the construction of a manufacturing plant manufacturing of vaccines in Quebec, for the period from March 2020 to August 2024. iv. The conditions and terms of reimbursement of amounts paid to Medicago under the grant(s) linked to - the development of vaccines against Covid-19 - clinical trials linked to the vaccine
Disposition: Disclosed in part
Number of pages: 35